Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2019-02-01 2019-01-25
Drug Identification Number 00778338 00778338
Brand name AXID AXID
Common or Proper name Nizatidine Nizatidine
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients NIZATIDINE NIZATIDINE
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 caps 100 caps
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-07-01 2019-07-01
Actual start date 2019-01-31
Estimated end date 2019-07-23 2019-07-23
Actual end date 2019-01-31
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments